Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets

Antiviral Research

Volumn 91, Issue 2, 2011, Pages 81-88

  Govorkova, Elena A ^a   Marathe, Bindumadhav M ^a   Prevost, Ashley ^a   Rehg, Jerold E ^a   Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Ferret model; Neuraminidase inhibitor; Oseltamivir; Pandemic 2009 H1N1 virus

Indexed keywords

OSELTAMIVIR; SIALIDASE INHIBITOR;

ARTICLE; DRUG EFFECT; DRUG EFFICACY; FERRET; HISTOLOGY; INFLAMMATION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; DOGS; DRUG RESISTANCE, VIRAL; FEMALE; FERRETS; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MICROBIAL SENSITIVITY TESTS; MUTATION; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; OXYGEN; PLAQUE ASSAY; PNEUMONIA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

ANIMALIA; INFLUENZA A VIRUS; MAMMALIA; MUSTELA; ORTHOMYXOVIRIDAE;

EID: 79958295687     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.05.008     Document Type: Article

References (37)

1. Anderson R.M. How well are we managing the influenza A/H1N1 pandemic in the UK?. BMJ 2009, 339:b2897.
2. Cao B., Li X.W., Mao Y., Wang J., Lu H.Z., Chen Y.S., Liang Z.A., Liang L., Zhang S.J., Zhang B., Gu L., Lu L.H., Wang D.Y., Wang C., A National Influenza Pandemic (H1N1), Clinical Investigation Group of China Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N. Engl. J. Med. 2009, 361:2507-2517.
3. Centers for Disease Control, Prevention Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:433-435.
4. Charlier C., Enouf V., Lanternier F., Grandadam M., Amazzough K., Blanche S., Lecuit M., Lortholary O., van der Werf S. Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy. Clin. Microbiol. Infect. 2009, 15:1189-1191.
5. Chen H., Wen X., To K.K., Wang P., Tse H., Chan J.F., Tsoi H.W., Fung K.S., Tse C.W., Lee R.A., Chan K.H., Yuen K.Y. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A (H1N1) 2009 virus from patients with severe disease in Hong Kong. China. J. Infect. Dis. 2010, 201:1517-1521.
6. Chen Z., Wang W., Zhou H., Suguitan A.L., Shambaugh C., Kim L., Zhao J., Kemble G., Jin H. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J. Virol. 2010, 84:44-51.
7. Deyde V.M., Sheu T.G., Trujillo A.A., Okomo-Adhiambo M., Garten R., Klimov A.I., Gubareva L.V. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 2010, 54:1102-1110.
8. Domínguez-Cherit G., Lapinsky S.E., Macias A.E., Pinto R., Espinosa-Perez L., de la Torre A., Poblano-Morales M., Baltazar-Torres J.A., Bautista E., Martinez A., Martinez M.A., Rivero E., Valdez R., Ruiz-Palacios G., Hernández M., Stewart T.E., Fowler R.A. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009, 302:1880-1887.
9. Gambotto A., Barratt-Boyes S.M., de Jong M.D., Neumann G., Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008, 371:1464-1475.
10. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., López-Gatell H., Olivera H., López I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009, 10:197-201.
11. Gaur A.H., Bagga B., Barman S., Hayden R., Lamptey A., Hoffman J.M., Bhojwani D., Flynn P.M., Tuomanen E., Webby R. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N. Engl. J. Med. 2010, 7:88-89.
12. Govorkova E.A., Ilyushina N.A., Boltz D.A., Douglas A., Yilmaz N., Webster R.G. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob. Agents Chemother. 2007, 51:1414-1424.
13. Gubareva L.V., Trujillo A.A., Okomo-Adhiambo M., Mishin V.P., Deyde V.M., Sleeman K., Nguyen H.T., Sheu T.G., Garten R.J., Shaw M.W., Fry A.M., Klimov A.I. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antivir. Ther. 2010, 15(8):1151-1159.
14. Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146:2275-2289.
15. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., Sakabe S., Imai M., Hatta Y., Watanabe S., Li C., Yamada S., Fujii K., Murakami S., Imai H., Kakugawa S., Ito M., Takano R., Iwatsuki-Horimoto K., Shimojima M., Horimoto T., Goto H., Takahashi K., Makino A., Ishigaki H., Nakayama M., Okamatsu M., Takahashi K., Warshauer D., Shult P.A., Saito R., Suzuki H., Furuta Y., Yamashita M., Mitamura K., Nakano K., Nakamura M., Brockman-Schneider R., Mitamura H., Yamazaki M., Sugaya N., Suresh M., Ozawa M., Neumann G., Gern J., Kida H., Ogasawara K., Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
16. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., Sugerman D.E., Druckenmiller J.K., Ritger K.A., Chugh R., Jasuja S., Deutscher M., Chen S., Walker J.D., Duchin J.S., Lett S., Soliva S., Wells E.V., Swerdlow D., Uyeki T.M., Fiore A.E., Olsen S.J., Fry A.M., Bridges C.B., Finelli L. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 2009, 361:1935-1944.
17. Kidd I.M., Down J., Nastouli E., Shulman R., Grant P.R., Howell D.C., Singer M. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 2009, 19:1036.
18. Lee V.J., Yap J., Cook A.R., Chen M.I., Tay J.K., Tan B.H., Loh J.P., Chew S.W., Koh W.H., Lin R., Cui L., Lee C.W., Sung W.K., Wong C.W., Hibberd M.L., Kang W.L., Seet B., Tambyah P.A. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N. Engl. J. Med. 2010, 362:2166-2174.
19. Li I.W., Hung I.F., To K.K., Chan K.H., Wong S.S., Chan J.F., Cheng V.C., Tsang O.T., Lai S.T., Lau Y.L., Yuen K.Y. The natural viral load profile of patients with pandemic 2009 influenza A (H1N1) and the effect of oseltamivir treatment. Chest 2010, 137:759-768.
20. Ling L.M., Chow A.L., Lye D.C., Tan A.S., Krishnan P., Cui L., Win N.N., Chan M., Lim P.L., Lee C.C., Leo Y.S. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin. Infect. Dis. 2010, 50:963-969.
21. Liu Y., Childs R.A., Matrosovich T., Wharton S., Palma A.S., Chai W., Daniels R., Gregory V., Uhlendorff J., Kiso M., Klenk H.D., Hay A., Feizi T., Matrosovich M. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A (H1N1) 2009 influenza virus. J. Virol. 2010, 84:12069-12074.
22. Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., Gustin K.M., Pearce M.B., Viswanathan K., Shriver Z.H., Raman R., Cox N.J., Sasisekharan R., Katz J.M., Tumpey T.M. Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice. Science 2009, 325:484-487.
23. McClellan K., Perry C.M. Oseltamivir: a review of its use in influenza. Drugs 2001, 61:263-283.
24. Munster V.J., de Wit E., van den Brand J.M., Herfst S., Schrauwen E.J., Bestebroer T.M., van de Vijver D., Boucher C.A., Koopmans M., Rimmelzwaan G.F., Kuiken T., Osterhaus A.D., Fouchier R.A. Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets. Science 2009, 325:481-483.
25. Nguyen H.T., Fry A.M., Loveless P.A., Klimov A.I., Gubareva L.V. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir. Clin. Infect. Dis. 2010, 51:983-984.
26. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94:287-296.
27. Reuman P.D., Keely S., Schiff G.M. Assessment of signs of influenza illness in the ferret model. J. Virol. Methods 1989, 24:27-34.
28. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436.
29. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S., Guan Y., Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 25:1122-1125.
30. Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., Martin W.J., Lamkanfi M., Webby R.J., Boyd K.L., Doherty P.C., Kanneganti T.D. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
31. van der Vries E., Stelma F.F., Boucher C.A. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N. Engl. J. Med. 2010, 363:1381-1382.
32. Wilson D.F., Lee W.M.F., Makonnen S., Finikova O., Apreleva S., Vinogradov S.A. Oxygen pressures in the interstitial space and their relationship to those in the blood plasma in resting skeletal muscle. J. Appl. Physiol. 2006, 101:1648-1656.
33. World Health Organization, 2009. Pandemic (H1N1) 2009 - update 60. Accessed 14 March 2011. http://www.who.int/csr/don/2009_08_04/en/print.html.
34. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista, E., Chotpitayasunondh, T., Gao, Z., Harper, S.A., Shaw, M., Uyeki, T.M., Zaki, S.R., Hayden, F.G., Hui, D.S., Kettner, J.D., Kumar, A., Lim, M., Shindo, N., Penn, C., Nicholson, K.G., 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362, 1708-1719.
35. Xu T., Qiao J., Zhao L., Wang G., He G., Li K., Tian Y., Gao M., Wang J., Wang H., Dong C. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am. J. Respir. Crit. Care. Med. 2006, 174:1011-1017.
36. Yu H., Liao Q., Yuan Y., Zhou L., Xiang N., Huai Y., Guo X., Zheng Y., van Doorn H.R., Farrar J., Gao Z., Feng Z., Wang Y., Yang W. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010, 341:c4779.
37. Yen H.-L., Monto A.S., Webster R.G., Govorkova E.A. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J. Infect. Dis. 2005, 192:665-672.